Paperpal Prime Logo

Journal of Psychopharmacology : Impact Factor & More

eISSN: 1461-7285pISSN: 0269-8811

Key Metrics

CiteScore
6.8
Impact Factor
< 5
SNIP
1.23
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Psychopharmacology

Journal of Psychopharmacology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher SAGE PUBLICATIONS LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1987
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Psychopharmacology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Psychopharmacology

The occurrence and potential role of mystical experiences in MDMA-assisted therapy for PTSD: A secondary analysis.
  • 6 Aug 2026
  • Journal of psychopharmacology (Oxford, England)
CB1 receptor-enriched functional connectivity analysis revealed target-specific modulation by cannabidiol in early psychosis.
  • 5 Aug 2026
  • Journal of psychopharmacology (Oxford, England)
Lithium toxicity from angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker co-prescription: A population-based cohort study.
  • 5 Aug 2026
  • Journal of psychopharmacology (Oxford, England)
A pharmacometric framework for norepinephrine transporter occupancy and dose equivalence across psychotropic medications.
  • 4 Aug 2026
  • Journal of psychopharmacology (Oxford, England)
Where is the sweet spot for psychedelic-enhanced fear extinction? An integrative quantitative synthesis of dose-effect patterns in rodent models.
  • 3 Aug 2026
  • Journal of psychopharmacology (Oxford, England)
Clarifying age filtering in a TriNetX-based study on pediatric antidepressant use and treatment-emergent mania.
  • 3 Aug 2026
  • Journal of psychopharmacology (Oxford, England)
The occurrence and potential role of mystical experiences in MDMA-assisted therapy for PTSD: A secondary analysis.
  • 6 Aug 2026
  • Journal of psychopharmacology (Oxford, England)
CB1 receptor-enriched functional connectivity analysis revealed target-specific modulation by cannabidiol in early psychosis.
  • 5 Aug 2026
  • Journal of psychopharmacology (Oxford, England)
Lithium toxicity from angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker co-prescription: A population-based cohort study.
  • 5 Aug 2026
  • Journal of psychopharmacology (Oxford, England)
A pharmacometric framework for norepinephrine transporter occupancy and dose equivalence across psychotropic medications.
  • 4 Aug 2026
  • Journal of psychopharmacology (Oxford, England)
Where is the sweet spot for psychedelic-enhanced fear extinction? An integrative quantitative synthesis of dose-effect patterns in rodent models.
  • 3 Aug 2026
  • Journal of psychopharmacology (Oxford, England)
Clarifying age filtering in a TriNetX-based study on pediatric antidepressant use and treatment-emergent mania.
  • 3 Aug 2026
  • Journal of psychopharmacology (Oxford, England)

FAQs on Journal of Psychopharmacology